597
Views
21
CrossRef citations to date
0
Altmetric
Research Article

The influence of HPMC concentration on release of theophylline or hydrocortisone from extended release mini-tablets

, , , , &
Pages 1167-1174 | Received 04 Dec 2011, Accepted 26 Mar 2012, Published online: 27 Apr 2012

References

  • Thomson SA, Tuleu C, Wong ICK, Keady S, Pitt KG, Sutcliffe AG. (2009). Minitablets: new modality to deliver medicines to preschool-aged children. Pediatrics, 123:235–238.
  • Nunn AJ. (2003). Making medicines that children can take. Arch Dis Child, 88:369–371.
  • Santen E, Barends DM, Frijlink HW. (2002). Breaking of scored tablets: a review. Eur J Pharm Biopharm, 53:139–145.
  • Costello I, Long PF, Wong IK, Tuleu C, Yeung V. (2007). Paediatric Drug Handling, Paediatric Formulations in Practice. London, UK: Pharmaceutical Press.
  • Broadhurst EC, Ford JL, Nunn AJ, Rowe PH, Roberts M. (2008). Dose uniformity of samples prepared from dispersible aspirin tablets for paediatric. Eur J Hosp Pharm, 14:27–31.
  • Breitkrutz J, Wessel T, Boss J. (1999). Dosage form for oral drug adminstration to children. Chapter 13. Introduction to Paediatric and Perinatal Drug Therapy. Updated from Paediatric and Perinatal Drug Therapy. pp. 25–33.
  • Lennartz P, Mielck JB. (1998). Minitabletting: improving the compactability of paracetamol powder mixtures. Int J Pharm, 173:75–85.
  • Lopes CM, Lobo JM, Pinto JF, Costa P. (2006). Compressed mini-tablets as a biphasic delivery system. Int J Pharm, 323:93–100.
  • Lopes CM, Sousa Lobo JM, Costa P, Pinto JF. (2006). Directly compressed mini matrix tablets containing ibuprofen: preparation and evaluation of sustained release. Drug Develop Indus Pharm, 32:95–106.
  • Greenhill LL, Findling RL, Swanson JM. (2002). A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics, 109:e39.
  • De Haan P, Lerk CF. (1984). Oral controlled release dosage forms. A review. Pharm Weekbl Sci, 6:57–67.
  • Grassi M, Grassi G. (2005). Mathematical modelling and controlled drug delivery: matrix systems. Curr Drug Deliv, 2:97–116.
  • Abdul S, Poddar SS. (2004). A flexible technology for modified release of drugs: multi layered tablets. J Control Release, 97:393–405.
  • Li CL, Martini LG, Ford JL, Roberts M. (2005). The use of hypromellose in oral drug delivery. J Pharm Pharmacol, 57:533–546.
  • Debono M, Price JN, Ross RJ. (2009). Novel strategies for hydrocortisone replacement. Best Pract Res Clin Endocrinol Metab, 23:221–232.
  • Heames K, Shah U, Riby P, Blair J, Ford J. (2009). Accuracy of 2.5 mg hydrocortisone doses from quatered 10 mg tablets. Endocrine Abstracts, 23:OC3.1.
  • Kotani A, Hashimoto M, Kotani T, Kusu F. (2011). Prepeak of trolox caused by theophylline and its application to the determination of theophylline in rat plasma. J Electroanal Chem, 656:85–90.
  • Simons E. (1985). Guideline for the use of Theophylline in children with asthma. Canada Med Assoc, 132:1011–1012.
  • Stubbs J, Haw C, Dickens G. (2008). Dose form modification - a common but potentially hazardous practice. A literature review and study of medication administration to older psychiatric inpatients. Int Psychogeriatr, 20:616–627.
  • Seton L, Khamar D, Bradshaw IJ, Hutcheon GA. (2010). Solid state forms of theophylline: presenting a new anhydrous polymorph. Crystal Growth & Des, 10:3879–3886.
  • Fell JT, Newton JM. (1968). The tensile strength of lactose tablets. J Pharm Pharmacol, 20:657–659.
  • Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. (1983). Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm, 15:25–35.
  • Ford JL, Mitchell K, Rowe P, Armstrong DJ, Elliott PNC, Rostron C, Hogan JE. (1991). Mathematical modelling of drug release from hydroxypropyl methylcellulose matrices: effect of temperature. Int J Pharm, 71:95–104.
  • Ford JL, Rubinstein MH, McCaul F, Hogan JE, Edgar PJ. (1987). Importance of drug type, tablet shape and added diluents on drug release kinetics from hydroxypropyl methylcellulose matrix tablets. Int J Pharm, 40:223–234.
  • Peppas NA. (1985). Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv, 60:110–111.
  • Wan LSC, Heng PWS, Wong LF. (1991). The effect of hydroxypropyl methylcellulose on water penetration into a matrix system. Int J Pharm, 73:111–116.
  • Tahara K, Yamamoto K, Nishihata T. (1995). Overall mechanism behind matrix sustained release (SR) tablets prepared with hydroxypropyl methylcellulose 2910. J Control Release, 35:59–66.
  • Yang L, Fassihi R. (1997). Examination of drug solubility, polymer types, hydrodynamics and loading dose on drug release behavior from a triple-layer asymmetric configuration delivery system. Int J Pharm, 155:219–229.
  • Fu XC, Wang GP, Liang WQ, Chow MS. (2004). Prediction of drug release from HPMC matrices: effect of physicochemical properties of drug and polymer concentration. J Control Release, 95:209–216.
  • Siepmann J, Peppas NA. (2000). Hydrophilic matrices for controlled drug delivery: an improved mathematical model to predict the resulting drug release kinetics (the “sequential layerâ model). Pharm Res, 17:1290–1298.
  • Siepmann J, Podual K, Sriwongjanya M, Peppas NA, Bodmeier R. (1999). A new model describing the swelling and drug release kinetics from hydroxypropyl methylcellulose tablets. J Pharm Sci, 88:65–72.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.